XML 21 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
REVENUES        
Total revenues $ 10,797 $ 10,951 $ 21,283 $ 16,334
OPERATING COSTS AND EXPENSES        
Cost of goods sold 1,140 200 2,972 293
License royalties 100 210 100 210
Research and development 26,420 19,778 49,332 41,357
Selling, general, and administrative 23,082 13,475 36,520 25,445
Total operating costs and expenses 50,742 33,663 88,924 67,305
Loss from operations (39,945) (22,712) (67,641) (50,971)
OTHER INCOME / (LOSS), NET        
Gain from sale of priority review voucher, net       62,010
Interest and other loss (1,186) (225) (1,558) (563)
NET INCOME / (LOSS) (41,131) (22,937) (69,199) 10,476
Other comprehensive income        
Foreign currency translation 1,422 78 1,733 513
COMPREHENSIVE INCOME / (LOSS) $ (39,709) $ (22,859) $ (67,466) $ 10,989
Net income / (loss) per share attributable to common stockholders, basic (in dollars per share) $ (0.94) $ (0.53) $ (1.58) $ 0.25
Weighted average common shares outstanding, basic (in shares) 43,718,748 43,569,482 43,713,967 42,724,813
Net income / (loss) per share attributable to common stockholders, diluted (in dollars per share) $ (0.94) $ (0.53) $ (1.58) $ 0.23
Weighted average common shares outstanding, diluted (in shares) 43,718,748 43,569,482 43,713,967 45,080,419
Product        
REVENUES        
Total revenues $ 9,797 $ 8,951 $ 20,283 $ 14,334
License        
REVENUES        
Total revenues $ 1,000 $ 2,000 $ 1,000 $ 2,000